Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 254-996-9
CAS number: 40601-76-1
A toxicokinetic assessment is available which describes the % of absorption after oral, inhalation and dermal exposures to Cyanox 1790 for risk assessment purposes. The assessment is based on physico-chemical properties of Cyanox 1790 and the available experimental data.
Once absorbed in the gastro-intestinal tract, Cyanox 1790 might be
metabolized. Excretion of Cyanox 1790 and its metabolites will occur via
the bile (high molecular weight) or the urine (low molecular weight).
Based on the high partition coefficient, Cyanox 1790 may accumulate in
adipose tissue. For risk assessment purposes, the oral absorption is set
at 10%, the inhalation absorption is set at 100% and the dermal
absorption is set at 10%.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
På den här webbplatsen används kakor. Syftet är att optimera din upplevelse av den.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again